nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A1—obesity	0.188	0.574	CbGaD
Procainamide—BCHE—obesity	0.139	0.426	CbGaD
Procainamide—SLC22A3—Methamphetamine—obesity	0.073	0.161	CbGbCtD
Procainamide—SLC22A4—Cimetidine—obesity	0.0626	0.139	CbGbCtD
Procainamide—SLC22A3—Cimetidine—obesity	0.057	0.126	CbGbCtD
Procainamide—SLC22A5—Methamphetamine—obesity	0.0453	0.1	CbGbCtD
Procainamide—SCN1A—Topiramate—obesity	0.0424	0.0938	CbGbCtD
Procainamide—SLC22A5—Cimetidine—obesity	0.0354	0.0783	CbGbCtD
Procainamide—SLC22A2—Cimetidine—obesity	0.0337	0.0746	CbGbCtD
Procainamide—SLC22A1—Cimetidine—obesity	0.0293	0.0648	CbGbCtD
Procainamide—SCN5A—Topiramate—obesity	0.029	0.0641	CbGbCtD
Procainamide—CYP2D6—Phentermine—obesity	0.0136	0.03	CbGbCtD
Procainamide—CYP2D6—Bupropion—obesity	0.0115	0.0255	CbGbCtD
Procainamide—CYP2D6—Methamphetamine—obesity	0.0108	0.024	CbGbCtD
Procainamide—CYP2D6—Cimetidine—obesity	0.00846	0.0187	CbGbCtD
Procainamide—Electrocardiogram change—Diethylpropion—obesity	0.00449	0.0505	CcSEcCtD
Procainamide—BCHE—diaphragm—obesity	0.00355	0.0871	CbGeAlD
Procainamide—Taste bitter—Orlistat—obesity	0.00258	0.0291	CcSEcCtD
Procainamide—SCN8A—hindbrain—obesity	0.00193	0.0473	CbGeAlD
Procainamide—SCN1A—hindbrain—obesity	0.00146	0.0358	CbGeAlD
Procainamide—Psychotic disorder—Methamphetamine—obesity	0.00146	0.0164	CcSEcCtD
Procainamide—Psychotic disorder—Benzphetamine—obesity	0.0014	0.0158	CcSEcCtD
Procainamide—SCN2A—hindbrain—obesity	0.00134	0.0328	CbGeAlD
Procainamide—Psychotic disorder—Phendimetrazine—obesity	0.00128	0.0144	CcSEcCtD
Procainamide—Abdominal pain upper—Phendimetrazine—obesity	0.0012	0.0135	CcSEcCtD
Procainamide—Cardiac failure—Phentermine—obesity	0.0011	0.0123	CcSEcCtD
Procainamide—Psychotic disorder—Phenylpropanolamine—obesity	0.00109	0.0123	CcSEcCtD
Procainamide—Psychotic disorder—Phentermine—obesity	0.00105	0.0118	CcSEcCtD
Procainamide—Cardiac arrest—Phentermine—obesity	0.00102	0.0115	CcSEcCtD
Procainamide—DNMT1—respiratory system—obesity	0.00101	0.0249	CbGeAlD
Procainamide—SCN7A—cardiovascular system—obesity	0.00101	0.0248	CbGeAlD
Procainamide—Supraventricular tachycardia—Sibutramine—obesity	0.000995	0.0112	CcSEcCtD
Procainamide—SCN11A—digestive system—obesity	0.000987	0.0243	CbGeAlD
Procainamide—Hepatic failure—Cimetidine—obesity	0.000986	0.0111	CcSEcCtD
Procainamide—Renal impairment—Cimetidine—obesity	0.000931	0.0105	CcSEcCtD
Procainamide—Psychotic disorder—Diethylpropion—obesity	0.000909	0.0102	CcSEcCtD
Procainamide—SCN7A—adipose tissue—obesity	0.000892	0.0219	CbGeAlD
Procainamide—ACHE—islet of Langerhans—obesity	0.000873	0.0214	CbGeAlD
Procainamide—Supraventricular tachycardia—Bupropion—obesity	0.000868	0.00977	CcSEcCtD
Procainamide—Psychotic disorder—Cimetidine—obesity	0.000865	0.00974	CcSEcCtD
Procainamide—Ventricular fibrillation—Sibutramine—obesity	0.000852	0.00959	CcSEcCtD
Procainamide—DNMT1—adrenal cortex—obesity	0.000851	0.0209	CbGeAlD
Procainamide—Probenecid—SLC16A7—obesity	0.00085	0.208	CrCbGaD
Procainamide—Flushing—Phendimetrazine—obesity	0.000841	0.00947	CcSEcCtD
Procainamide—SCN7A—adrenal gland—obesity	0.0008	0.0196	CbGeAlD
Procainamide—DNMT1—cardiovascular system—obesity	0.000777	0.0191	CbGeAlD
Procainamide—Abdominal discomfort—Diethylpropion—obesity	0.000772	0.00869	CcSEcCtD
Procainamide—Hallucination—Phenylpropanolamine—obesity	0.00077	0.00867	CcSEcCtD
Procainamide—Hallucination—Phentermine—obesity	0.000737	0.0083	CcSEcCtD
Procainamide—Flushing—Phenylpropanolamine—obesity	0.000718	0.00809	CcSEcCtD
Procainamide—Neutropenia—Cimetidine—obesity	0.000716	0.00806	CcSEcCtD
Procainamide—SCN9A—pituitary gland—obesity	0.000701	0.0172	CbGeAlD
Procainamide—SCN9A—adipose tissue—obesity	0.000699	0.0172	CbGeAlD
Procainamide—SCN7A—endocrine gland—obesity	0.000694	0.017	CbGeAlD
Procainamide—DNMT1—pituitary gland—obesity	0.000688	0.0169	CbGeAlD
Procainamide—DNMT1—adipose tissue—obesity	0.000685	0.0168	CbGeAlD
Procainamide—Anorexia—Benzphetamine—obesity	0.000673	0.00758	CcSEcCtD
Procainamide—Renal failure—Cimetidine—obesity	0.000671	0.00756	CcSEcCtD
Procainamide—Agranulocytosis—Diethylpropion—obesity	0.00067	0.00754	CcSEcCtD
Procainamide—Ventricular tachycardia—Sibutramine—obesity	0.000652	0.00734	CcSEcCtD
Procainamide—DNMT1—digestive system—obesity	0.000645	0.0158	CbGeAlD
Procainamide—Agranulocytosis—Cimetidine—obesity	0.000637	0.00717	CcSEcCtD
Procainamide—SLC22A4—respiratory system—obesity	0.000628	0.0154	CbGeAlD
Procainamide—SCN9A—adrenal gland—obesity	0.000627	0.0154	CbGeAlD
Procainamide—SCN4A—pituitary gland—obesity	0.000626	0.0154	CbGeAlD
Procainamide—SCN7A—liver—obesity	0.000625	0.0154	CbGeAlD
Procainamide—Bradycardia—Cimetidine—obesity	0.000624	0.00703	CcSEcCtD
Procainamide—SCN4A—adipose tissue—obesity	0.000623	0.0153	CbGeAlD
Procainamide—SCN8A—endocrine gland—obesity	0.000618	0.0152	CbGeAlD
Procainamide—DNMT1—adrenal gland—obesity	0.000615	0.0151	CbGeAlD
Procainamide—Decreased appetite—Benzphetamine—obesity	0.000614	0.00691	CcSEcCtD
Procainamide—Anorexia—Phendimetrazine—obesity	0.000613	0.00691	CcSEcCtD
Procainamide—Hallucination—Cimetidine—obesity	0.00061	0.00687	CcSEcCtD
Procainamide—Hepatic enzyme increased—Bupropion—obesity	0.000601	0.00677	CcSEcCtD
Procainamide—Benzocaine—CES1—obesity	0.000591	0.145	CrCbGaD
Procainamide—Urticaria—Methamphetamine—obesity	0.000582	0.00655	CcSEcCtD
Procainamide—Urticaria—Benzphetamine—obesity	0.000561	0.00632	CcSEcCtD
Procainamide—Decreased appetite—Phendimetrazine—obesity	0.000559	0.0063	CcSEcCtD
Procainamide—SCN4A—adrenal gland—obesity	0.000559	0.0137	CbGeAlD
Procainamide—Confusional state—Phenylpropanolamine—obesity	0.000554	0.00624	CcSEcCtD
Procainamide—SCN2A—pituitary gland—obesity	0.000554	0.0136	CbGeAlD
Procainamide—SCN5A—cardiovascular system—obesity	0.000548	0.0135	CbGeAlD
Procainamide—Hepatic failure—Orlistat—obesity	0.000544	0.00613	CcSEcCtD
Procainamide—Hypersensitivity—Methamphetamine—obesity	0.00054	0.00607	CcSEcCtD
Procainamide—SLC22A2—digestive system—obesity	0.000539	0.0132	CbGeAlD
Procainamide—Sunitinib—STK11—obesity	0.000535	0.131	CrCbGaD
Procainamide—SCN10A—pituitary gland—obesity	0.000534	0.0131	CbGeAlD
Procainamide—DNMT1—endocrine gland—obesity	0.000533	0.0131	CbGeAlD
Procainamide—Ill-defined disorder—Diethylpropion—obesity	0.00052	0.00586	CcSEcCtD
Procainamide—Hypersensitivity—Benzphetamine—obesity	0.00052	0.00586	CcSEcCtD
Procainamide—Rash maculo-papular—Bupropion—obesity	0.000517	0.00582	CcSEcCtD
Procainamide—Hypotension—Phenylpropanolamine—obesity	0.000514	0.00578	CcSEcCtD
Procainamide—Abdominal pain—Phendimetrazine—obesity	0.000509	0.00573	CcSEcCtD
Procainamide—Malaise—Diethylpropion—obesity	0.000506	0.00569	CcSEcCtD
Procainamide—Arthritis—Orlistat—obesity	0.000503	0.00567	CcSEcCtD
Procainamide—Diarrhoea—Methamphetamine—obesity	0.000501	0.00564	CcSEcCtD
Procainamide—Atrial fibrillation—Sibutramine—obesity	0.0005	0.00562	CcSEcCtD
Procainamide—ACHE—adrenal gland—obesity	0.000499	0.0123	CbGeAlD
Procainamide—Renal impairment—Sibutramine—obesity	0.000497	0.0056	CcSEcCtD
Procainamide—Arthritis—Sibutramine—obesity	0.000487	0.00548	CcSEcCtD
Procainamide—SCN3A—pituitary gland—obesity	0.000487	0.012	CbGeAlD
Procainamide—Convulsion—Diethylpropion—obesity	0.000486	0.00547	CcSEcCtD
Procainamide—SCN3A—adipose tissue—obesity	0.000485	0.0119	CbGeAlD
Procainamide—Dizziness—Methamphetamine—obesity	0.000484	0.00545	CcSEcCtD
Procainamide—Diarrhoea—Benzphetamine—obesity	0.000483	0.00544	CcSEcCtD
Procainamide—Malaise—Cimetidine—obesity	0.000481	0.00542	CcSEcCtD
Procainamide—DNMT1—liver—obesity	0.00048	0.0118	CbGeAlD
Procainamide—Myalgia—Diethylpropion—obesity	0.000477	0.00538	CcSEcCtD
Procainamide—Discomfort—Diethylpropion—obesity	0.000472	0.00531	CcSEcCtD
Procainamide—Dizziness—Benzphetamine—obesity	0.000467	0.00526	CcSEcCtD
Procainamide—CHRM2—cardiovascular system—obesity	0.000467	0.0115	CbGeAlD
Procainamide—Psychotic disorder—Sibutramine—obesity	0.000462	0.00521	CcSEcCtD
Procainamide—SCN5A—digestive system—obesity	0.000455	0.0112	CbGeAlD
Procainamide—Arthralgia—Cimetidine—obesity	0.000454	0.00511	CcSEcCtD
Procainamide—Myalgia—Cimetidine—obesity	0.000454	0.00511	CcSEcCtD
Procainamide—Feeling abnormal—Phenylpropanolamine—obesity	0.000453	0.0051	CcSEcCtD
Procainamide—Cardiac arrest—Sibutramine—obesity	0.00045	0.00507	CcSEcCtD
Procainamide—Abdominal pain upper—Orlistat—obesity	0.000447	0.00503	CcSEcCtD
Procainamide—Diarrhoea—Phendimetrazine—obesity	0.00044	0.00496	CcSEcCtD
Procainamide—CYP2D6—hindbrain—obesity	0.000439	0.0108	CbGeAlD
Procainamide—Confusional state—Cimetidine—obesity	0.000439	0.00494	CcSEcCtD
Procainamide—SCN3A—adrenal gland—obesity	0.000435	0.0107	CbGeAlD
Procainamide—SCN2A—endocrine gland—obesity	0.000429	0.0105	CbGeAlD
Procainamide—Thrombocytopenia—Cimetidine—obesity	0.000426	0.0048	CcSEcCtD
Procainamide—SLC22A4—pituitary gland—obesity	0.000426	0.0105	CbGeAlD
Procainamide—Dizziness—Phendimetrazine—obesity	0.000426	0.00479	CcSEcCtD
Procainamide—Arthritis—Bupropion—obesity	0.000425	0.00478	CcSEcCtD
Procainamide—SLC22A4—adipose tissue—obesity	0.000424	0.0104	CbGeAlD
Procainamide—Lethargy—Bupropion—obesity	0.000421	0.00474	CcSEcCtD
Procainamide—Nausea—Benzphetamine—obesity	0.000419	0.00472	CcSEcCtD
Procainamide—Urticaria—Phentermine—obesity	0.000418	0.00471	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Diethylpropion—obesity	0.000417	0.0047	CcSEcCtD
Procainamide—Abdominal pain—Phentermine—obesity	0.000416	0.00468	CcSEcCtD
Procainamide—SLC22A5—respiratory system—obesity	0.000416	0.0102	CbGeAlD
Procainamide—SCN10A—endocrine gland—obesity	0.000414	0.0102	CbGeAlD
Procainamide—Abdominal discomfort—Orlistat—obesity	0.000405	0.00456	CcSEcCtD
Procainamide—Eosinophilia—Sibutramine—obesity	0.000405	0.00456	CcSEcCtD
Procainamide—Hypersensitivity—Phenylpropanolamine—obesity	0.000405	0.00456	CcSEcCtD
Procainamide—BCHE—respiratory system—obesity	0.000405	0.00995	CbGeAlD
Procainamide—SLC22A1—adipose tissue—obesity	0.000404	0.00993	CbGeAlD
Procainamide—Psychotic disorder—Bupropion—obesity	0.000403	0.00454	CcSEcCtD
Procainamide—SLC22A4—digestive system—obesity	0.0004	0.00981	CbGeAlD
Procainamide—Musculoskeletal discomfort—Cimetidine—obesity	0.000397	0.00447	CcSEcCtD
Procainamide—Sunitinib—RPS6KB1—obesity	0.000394	0.0965	CrCbGaD
Procainamide—Oliguria—Topiramate—obesity	0.000393	0.00443	CcSEcCtD
Procainamide—SLC22A3—adipose tissue—obesity	0.000386	0.00949	CbGeAlD
Procainamide—Hepatic enzyme increased—Topiramate—obesity	0.000383	0.00431	CcSEcCtD
Procainamide—Nausea—Phendimetrazine—obesity	0.000382	0.0043	CcSEcCtD
Procainamide—SLC22A4—adrenal gland—obesity	0.000381	0.00935	CbGeAlD
Procainamide—Asthenia—Phentermine—obesity	0.000377	0.00425	CcSEcCtD
Procainamide—Feeling abnormal—Diethylpropion—obesity	0.000377	0.00425	CcSEcCtD
Procainamide—Abdominal pain upper—Bupropion—obesity	0.000377	0.00424	CcSEcCtD
Procainamide—Depression—Orlistat—obesity	0.000376	0.00423	CcSEcCtD
Procainamide—Renal failure—Orlistat—obesity	0.000371	0.00417	CcSEcCtD
Procainamide—Depression—Sibutramine—obesity	0.000364	0.0041	CcSEcCtD
Procainamide—Urticaria—Diethylpropion—obesity	0.000364	0.00409	CcSEcCtD
Procainamide—Dizziness—Phenylpropanolamine—obesity	0.000364	0.00409	CcSEcCtD
Procainamide—Diarrhoea—Phentermine—obesity	0.00036	0.00405	CcSEcCtD
Procainamide—Feeling abnormal—Cimetidine—obesity	0.000359	0.00404	CcSEcCtD
Procainamide—Renal failure—Sibutramine—obesity	0.000359	0.00404	CcSEcCtD
Procainamide—Vomiting—Phenylpropanolamine—obesity	0.00035	0.00394	CcSEcCtD
Procainamide—SLC22A5—adrenal cortex—obesity	0.000349	0.00857	CbGeAlD
Procainamide—Dizziness—Phentermine—obesity	0.000348	0.00392	CcSEcCtD
Procainamide—SLC22A3—adrenal gland—obesity	0.000346	0.00851	CbGeAlD
Procainamide—Body temperature increased—Cimetidine—obesity	0.000344	0.00388	CcSEcCtD
Procainamide—Abdominal discomfort—Bupropion—obesity	0.000342	0.00385	CcSEcCtD
Procainamide—Vomiting—Phentermine—obesity	0.000335	0.00377	CcSEcCtD
Procainamide—Bradycardia—Sibutramine—obesity	0.000333	0.00375	CcSEcCtD
Procainamide—Rash maculo-papular—Topiramate—obesity	0.000329	0.00371	CcSEcCtD
Procainamide—Sunitinib—TYK2—obesity	0.000327	0.08	CrCbGaD
Procainamide—Nausea—Phenylpropanolamine—obesity	0.000327	0.00368	CcSEcCtD
Procainamide—Hypersensitivity—Cimetidine—obesity	0.000321	0.00361	CcSEcCtD
Procainamide—CHRM2—endocrine gland—obesity	0.00032	0.00786	CbGeAlD
Procainamide—SLC22A1—endocrine gland—obesity	0.000314	0.00772	CbGeAlD
Procainamide—Diarrhoea—Diethylpropion—obesity	0.000313	0.00353	CcSEcCtD
Procainamide—Nausea—Phentermine—obesity	0.000312	0.00352	CcSEcCtD
Procainamide—Asthenia—Cimetidine—obesity	0.000312	0.00352	CcSEcCtD
Procainamide—BCHE—cardiovascular system—obesity	0.00031	0.00762	CbGeAlD
Procainamide—Dizziness—Diethylpropion—obesity	0.000303	0.00341	CcSEcCtD
Procainamide—SLC22A3—endocrine gland—obesity	0.0003	0.00738	CbGeAlD
Procainamide—Diarrhoea—Cimetidine—obesity	0.000298	0.00335	CcSEcCtD
Procainamide—Chills—Sibutramine—obesity	0.000294	0.00331	CcSEcCtD
Procainamide—Hepatic failure—Topiramate—obesity	0.000293	0.00329	CcSEcCtD
Procainamide—Vomiting—Diethylpropion—obesity	0.000291	0.00328	CcSEcCtD
Procainamide—Dysgeusia—Orlistat—obesity	0.000288	0.00325	CcSEcCtD
Procainamide—Dizziness—Cimetidine—obesity	0.000288	0.00324	CcSEcCtD
Procainamide—Hallucination—Bupropion—obesity	0.000284	0.0032	CcSEcCtD
Procainamide—SLC22A1—liver—obesity	0.000283	0.00696	CbGeAlD
Procainamide—SLC22A5—pituitary gland—obesity	0.000282	0.00693	CbGeAlD
Procainamide—SLC22A5—adipose tissue—obesity	0.000281	0.0069	CbGeAlD
Procainamide—Dysgeusia—Sibutramine—obesity	0.000279	0.00314	CcSEcCtD
Procainamide—Vomiting—Cimetidine—obesity	0.000277	0.00312	CcSEcCtD
Procainamide—BCHE—pituitary gland—obesity	0.000275	0.00675	CbGeAlD
Procainamide—BCHE—adipose tissue—obesity	0.000274	0.00672	CbGeAlD
Procainamide—Ill-defined disorder—Orlistat—obesity	0.000273	0.00308	CcSEcCtD
Procainamide—Nausea—Diethylpropion—obesity	0.000272	0.00306	CcSEcCtD
Procainamide—SLC22A3—liver—obesity	0.000271	0.00665	CbGeAlD
Procainamide—Angioedema—Orlistat—obesity	0.000269	0.00303	CcSEcCtD
Procainamide—Lethargy—Topiramate—obesity	0.000268	0.00302	CcSEcCtD
Procainamide—Malaise—Orlistat—obesity	0.000266	0.00299	CcSEcCtD
Procainamide—Flushing—Bupropion—obesity	0.000265	0.00298	CcSEcCtD
Procainamide—Cardiac disorder—Bupropion—obesity	0.000265	0.00298	CcSEcCtD
Procainamide—Ill-defined disorder—Sibutramine—obesity	0.000265	0.00298	CcSEcCtD
Procainamide—SLC22A5—digestive system—obesity	0.000264	0.00649	CbGeAlD
Procainamide—Angioedema—Sibutramine—obesity	0.000261	0.00293	CcSEcCtD
Procainamide—Nausea—Cimetidine—obesity	0.000259	0.00291	CcSEcCtD
Procainamide—BCHE—digestive system—obesity	0.000258	0.00633	CbGeAlD
Procainamide—Malaise—Sibutramine—obesity	0.000257	0.00289	CcSEcCtD
Procainamide—Psychotic disorder—Topiramate—obesity	0.000257	0.00289	CcSEcCtD
Procainamide—Chills—Bupropion—obesity	0.000256	0.00288	CcSEcCtD
Procainamide—Convulsion—Orlistat—obesity	0.000255	0.00287	CcSEcCtD
Procainamide—SLC22A5—adrenal gland—obesity	0.000252	0.00619	CbGeAlD
Procainamide—Myalgia—Orlistat—obesity	0.000251	0.00282	CcSEcCtD
Procainamide—Discomfort—Orlistat—obesity	0.000248	0.00279	CcSEcCtD
Procainamide—Convulsion—Sibutramine—obesity	0.000247	0.00278	CcSEcCtD
Procainamide—BCHE—adrenal gland—obesity	0.000245	0.00603	CbGeAlD
Procainamide—Dysgeusia—Bupropion—obesity	0.000243	0.00274	CcSEcCtD
Procainamide—Arthralgia—Sibutramine—obesity	0.000243	0.00273	CcSEcCtD
Procainamide—Myalgia—Sibutramine—obesity	0.000243	0.00273	CcSEcCtD
Procainamide—Abdominal pain upper—Topiramate—obesity	0.00024	0.0027	CcSEcCtD
Procainamide—Discomfort—Sibutramine—obesity	0.00024	0.0027	CcSEcCtD
Procainamide—Confusional state—Sibutramine—obesity	0.000235	0.00264	CcSEcCtD
Procainamide—Ill-defined disorder—Bupropion—obesity	0.000231	0.0026	CcSEcCtD
Procainamide—Shock—Sibutramine—obesity	0.000229	0.00258	CcSEcCtD
Procainamide—Thrombocytopenia—Sibutramine—obesity	0.000228	0.00257	CcSEcCtD
Procainamide—Oxybuprocaine—BCHE—obesity	0.000227	0.0557	CrCbGaD
Procainamide—Angioedema—Bupropion—obesity	0.000227	0.00256	CcSEcCtD
Procainamide—Eosinophilia—Topiramate—obesity	0.000225	0.00253	CcSEcCtD
Procainamide—Malaise—Bupropion—obesity	0.000224	0.00252	CcSEcCtD
Procainamide—Anorexia—Sibutramine—obesity	0.000222	0.0025	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Orlistat—obesity	0.000219	0.00247	CcSEcCtD
Procainamide—Abdominal discomfort—Topiramate—obesity	0.000218	0.00245	CcSEcCtD
Procainamide—Hypotension—Sibutramine—obesity	0.000217	0.00245	CcSEcCtD
Procainamide—Convulsion—Bupropion—obesity	0.000215	0.00242	CcSEcCtD
Procainamide—BCHE—endocrine gland—obesity	0.000213	0.00523	CbGeAlD
Procainamide—Neutropenia—Topiramate—obesity	0.000213	0.00239	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Sibutramine—obesity	0.000212	0.00239	CcSEcCtD
Procainamide—Myalgia—Bupropion—obesity	0.000212	0.00238	CcSEcCtD
Procainamide—Arthralgia—Bupropion—obesity	0.000212	0.00238	CcSEcCtD
Procainamide—Chloroprocaine—BCHE—obesity	0.000211	0.0517	CrCbGaD
Procainamide—Discomfort—Bupropion—obesity	0.000209	0.00235	CcSEcCtD
Procainamide—Decreased appetite—Orlistat—obesity	0.000209	0.00235	CcSEcCtD
Procainamide—Confusional state—Bupropion—obesity	0.000205	0.0023	CcSEcCtD
Procainamide—Decreased appetite—Sibutramine—obesity	0.000202	0.00228	CcSEcCtD
Procainamide—Depression—Topiramate—obesity	0.000202	0.00227	CcSEcCtD
Procainamide—Cinchocaine—BCHE—obesity	0.000202	0.0494	CrCbGaD
Procainamide—Procaine—BCHE—obesity	0.000202	0.0494	CrCbGaD
Procainamide—Shock—Bupropion—obesity	0.0002	0.00225	CcSEcCtD
Procainamide—Renal failure—Topiramate—obesity	0.000199	0.00224	CcSEcCtD
Procainamide—Thrombocytopenia—Bupropion—obesity	0.000199	0.00224	CcSEcCtD
Procainamide—Feeling abnormal—Orlistat—obesity	0.000198	0.00223	CcSEcCtD
Procainamide—SLC22A5—liver—obesity	0.000197	0.00484	CbGeAlD
Procainamide—Gastrointestinal pain—Orlistat—obesity	0.000197	0.00221	CcSEcCtD
Procainamide—Anorexia—Bupropion—obesity	0.000193	0.00218	CcSEcCtD
Procainamide—BCHE—liver—obesity	0.000192	0.00471	CbGeAlD
Procainamide—Feeling abnormal—Sibutramine—obesity	0.000192	0.00216	CcSEcCtD
Procainamide—Urticaria—Orlistat—obesity	0.000191	0.00215	CcSEcCtD
Procainamide—Gastrointestinal pain—Sibutramine—obesity	0.00019	0.00214	CcSEcCtD
Procainamide—Abdominal pain—Orlistat—obesity	0.00019	0.00214	CcSEcCtD
Procainamide—Body temperature increased—Orlistat—obesity	0.00019	0.00214	CcSEcCtD
Procainamide—Hypotension—Bupropion—obesity	0.00019	0.00213	CcSEcCtD
Procainamide—Agranulocytosis—Topiramate—obesity	0.000189	0.00213	CcSEcCtD
Procainamide—Bradycardia—Topiramate—obesity	0.000185	0.00209	CcSEcCtD
Procainamide—Urticaria—Sibutramine—obesity	0.000185	0.00208	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Bupropion—obesity	0.000185	0.00208	CcSEcCtD
Procainamide—Body temperature increased—Sibutramine—obesity	0.000184	0.00207	CcSEcCtD
Procainamide—Abdominal pain—Sibutramine—obesity	0.000184	0.00207	CcSEcCtD
Procainamide—Probenecid—SLC22A1—obesity	0.000183	0.0448	CrCbGaD
Procainamide—Hallucination—Topiramate—obesity	0.000181	0.00204	CcSEcCtD
Procainamide—Aminohippurate—SLC22A1—obesity	0.000181	0.0442	CrCbGaD
Procainamide—Hypersensitivity—Orlistat—obesity	0.000177	0.00199	CcSEcCtD
Procainamide—Decreased appetite—Bupropion—obesity	0.000176	0.00199	CcSEcCtD
Procainamide—Asthenia—Orlistat—obesity	0.000172	0.00194	CcSEcCtD
Procainamide—Hypersensitivity—Sibutramine—obesity	0.000171	0.00193	CcSEcCtD
Procainamide—CYP2D6—digestive system—obesity	0.000171	0.00419	CbGeAlD
Procainamide—Pruritus—Orlistat—obesity	0.00017	0.00192	CcSEcCtD
Procainamide—Cardiac disorder—Topiramate—obesity	0.000169	0.0019	CcSEcCtD
Procainamide—Flushing—Topiramate—obesity	0.000169	0.0019	CcSEcCtD
Procainamide—Feeling abnormal—Bupropion—obesity	0.000167	0.00188	CcSEcCtD
Procainamide—Asthenia—Sibutramine—obesity	0.000167	0.00188	CcSEcCtD
Procainamide—Gastrointestinal pain—Bupropion—obesity	0.000166	0.00187	CcSEcCtD
Procainamide—Pruritus—Sibutramine—obesity	0.000165	0.00185	CcSEcCtD
Procainamide—Diarrhoea—Orlistat—obesity	0.000164	0.00185	CcSEcCtD
Procainamide—Chills—Topiramate—obesity	0.000163	0.00184	CcSEcCtD
Procainamide—Urticaria—Bupropion—obesity	0.000161	0.00181	CcSEcCtD
Procainamide—Abdominal pain—Bupropion—obesity	0.00016	0.00181	CcSEcCtD
Procainamide—Body temperature increased—Bupropion—obesity	0.00016	0.00181	CcSEcCtD
Procainamide—Diarrhoea—Sibutramine—obesity	0.000159	0.00179	CcSEcCtD
Procainamide—Dizziness—Orlistat—obesity	0.000159	0.00179	CcSEcCtD
Procainamide—Dysgeusia—Topiramate—obesity	0.000155	0.00175	CcSEcCtD
Procainamide—Dizziness—Sibutramine—obesity	0.000154	0.00173	CcSEcCtD
Procainamide—Vomiting—Orlistat—obesity	0.000153	0.00172	CcSEcCtD
Procainamide—Hypersensitivity—Bupropion—obesity	0.000149	0.00168	CcSEcCtD
Procainamide—Vomiting—Sibutramine—obesity	0.000148	0.00167	CcSEcCtD
Procainamide—Ill-defined disorder—Topiramate—obesity	0.000147	0.00165	CcSEcCtD
Procainamide—Asthenia—Bupropion—obesity	0.000146	0.00164	CcSEcCtD
Procainamide—Pruritus—Bupropion—obesity	0.000144	0.00162	CcSEcCtD
Procainamide—Nausea—Orlistat—obesity	0.000143	0.00161	CcSEcCtD
Procainamide—Malaise—Topiramate—obesity	0.000143	0.00161	CcSEcCtD
Procainamide—CYP2D6—endocrine gland—obesity	0.000141	0.00346	CbGeAlD
Procainamide—Diarrhoea—Bupropion—obesity	0.000139	0.00156	CcSEcCtD
Procainamide—Nausea—Sibutramine—obesity	0.000138	0.00156	CcSEcCtD
Procainamide—Convulsion—Topiramate—obesity	0.000137	0.00154	CcSEcCtD
Procainamide—Myalgia—Topiramate—obesity	0.000135	0.00152	CcSEcCtD
Procainamide—Arthralgia—Topiramate—obesity	0.000135	0.00152	CcSEcCtD
Procainamide—Dizziness—Bupropion—obesity	0.000134	0.00151	CcSEcCtD
Procainamide—Discomfort—Topiramate—obesity	0.000133	0.0015	CcSEcCtD
Procainamide—Confusional state—Topiramate—obesity	0.00013	0.00147	CcSEcCtD
Procainamide—Vomiting—Bupropion—obesity	0.000129	0.00145	CcSEcCtD
Procainamide—Metoclopramide—DRD2—obesity	0.000128	0.0312	CrCbGaD
Procainamide—Shock—Topiramate—obesity	0.000127	0.00143	CcSEcCtD
Procainamide—CYP2D6—liver—obesity	0.000127	0.00312	CbGeAlD
Procainamide—Thrombocytopenia—Topiramate—obesity	0.000127	0.00142	CcSEcCtD
Procainamide—Anorexia—Topiramate—obesity	0.000123	0.00139	CcSEcCtD
Procainamide—Hypotension—Topiramate—obesity	0.000121	0.00136	CcSEcCtD
Procainamide—Nausea—Bupropion—obesity	0.00012	0.00136	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Topiramate—obesity	0.000118	0.00133	CcSEcCtD
Procainamide—Decreased appetite—Topiramate—obesity	0.000112	0.00126	CcSEcCtD
Procainamide—Feeling abnormal—Topiramate—obesity	0.000106	0.0012	CcSEcCtD
Procainamide—Gastrointestinal pain—Topiramate—obesity	0.000106	0.00119	CcSEcCtD
Procainamide—Urticaria—Topiramate—obesity	0.000103	0.00116	CcSEcCtD
Procainamide—Abdominal pain—Topiramate—obesity	0.000102	0.00115	CcSEcCtD
Procainamide—Body temperature increased—Topiramate—obesity	0.000102	0.00115	CcSEcCtD
Procainamide—Hypersensitivity—Topiramate—obesity	9.52e-05	0.00107	CcSEcCtD
Procainamide—Asthenia—Topiramate—obesity	9.27e-05	0.00104	CcSEcCtD
Procainamide—Pruritus—Topiramate—obesity	9.14e-05	0.00103	CcSEcCtD
Procainamide—Diarrhoea—Topiramate—obesity	8.84e-05	0.000996	CcSEcCtD
Procainamide—Dizziness—Topiramate—obesity	8.55e-05	0.000962	CcSEcCtD
Procainamide—Vomiting—Topiramate—obesity	8.22e-05	0.000925	CcSEcCtD
Procainamide—Nausea—Topiramate—obesity	7.68e-05	0.000864	CcSEcCtD
Procainamide—Probenecid—ALB—obesity	5.58e-05	0.0137	CrCbGaD
Procainamide—CHRM2—Signaling Pathways—AKR1C3—obesity	4.24e-06	4.87e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMOX1—obesity	4.22e-06	4.85e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GPX1—obesity	4.22e-06	4.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2A—obesity	4.2e-06	4.83e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—C3—obesity	4.2e-06	4.82e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AGT—obesity	4.15e-06	4.77e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GNAS—obesity	4.13e-06	4.75e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NPS—obesity	4.13e-06	4.74e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CD36—obesity	4.11e-06	4.72e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPA—obesity	4.1e-06	4.71e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CD—obesity	4.1e-06	4.71e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOE—obesity	4.06e-06	4.67e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—F2—obesity	4.06e-06	4.66e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PRKCB—obesity	4.06e-06	4.66e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2C—obesity	4.05e-06	4.65e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DRD1—obesity	4.05e-06	4.65e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOB—obesity	4.05e-06	4.65e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—obesity	4.04e-06	4.65e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CAV1—obesity	4.03e-06	4.63e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOA1—obesity	4.02e-06	4.62e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPIN1—obesity	4.02e-06	4.61e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—COMT—obesity	4.01e-06	4.61e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AGT—obesity	3.99e-06	4.58e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GNB3—obesity	3.96e-06	4.54e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARGC1A—obesity	3.96e-06	4.54e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NTRK2—obesity	3.94e-06	4.52e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMOX1—obesity	3.94e-06	4.52e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA5—obesity	3.93e-06	4.52e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRB1—obesity	3.92e-06	4.5e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—obesity	3.9e-06	4.48e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CG—obesity	3.88e-06	4.46e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—obesity	3.87e-06	4.44e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3R1—obesity	3.87e-06	4.44e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LPL—obesity	3.86e-06	4.44e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GNAS—obesity	3.85e-06	4.42e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.85e-06	4.42e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PARP1—obesity	3.84e-06	4.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GHRL—obesity	3.84e-06	4.41e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARA—obesity	3.82e-06	4.39e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DRD4—obesity	3.81e-06	4.37e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOB—obesity	3.77e-06	4.33e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GPX1—obesity	3.77e-06	4.33e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CLOCK—obesity	3.75e-06	4.31e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC22A1—obesity	3.75e-06	4.31e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AGT—obesity	3.7e-06	4.25e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—POMC—obesity	3.7e-06	4.25e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—F2—obesity	3.69e-06	4.23e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PRKCB—obesity	3.69e-06	4.23e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CD36—obesity	3.67e-06	4.22e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CG—obesity	3.67e-06	4.21e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SULT2A1—obesity	3.66e-06	4.2e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GLP1R—obesity	3.66e-06	4.2e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CNR1—obesity	3.63e-06	4.18e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOE—obesity	3.63e-06	4.17e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LPL—obesity	3.6e-06	4.14e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—DPYD—obesity	3.6e-06	4.13e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CAV1—obesity	3.59e-06	4.13e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOA1—obesity	3.58e-06	4.12e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CB—obesity	3.57e-06	4.1e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TCF7L2—obesity	3.57e-06	4.1e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT2—obesity	3.55e-06	4.08e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DRD2—obesity	3.55e-06	4.07e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—obesity	3.54e-06	4.07e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—obesity	3.54e-06	4.06e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CG—obesity	3.53e-06	4.05e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GPX1—obesity	3.51e-06	4.04e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GCG—obesity	3.51e-06	4.03e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTPN1—obesity	3.51e-06	4.03e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POMC—obesity	3.49e-06	4.01e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—obesity	3.48e-06	4e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—INS—obesity	3.47e-06	3.99e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PRKAR2B—obesity	3.46e-06	3.98e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—DCN—obesity	3.44e-06	3.95e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.43e-06	3.94e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CD36—obesity	3.42e-06	3.93e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CD—obesity	3.41e-06	3.92e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARA—obesity	3.41e-06	3.92e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—POMC—obesity	3.36e-06	3.86e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRL—obesity	3.35e-06	3.85e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CPT1A—obesity	3.34e-06	3.84e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AGT—obesity	3.31e-06	3.8e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STK11—obesity	3.3e-06	3.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL2—obesity	3.29e-06	3.77e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NAMPT—obesity	3.28e-06	3.77e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CG—obesity	3.27e-06	3.76e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLG—obesity	3.26e-06	3.75e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LIPC—obesity	3.26e-06	3.74e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GCK—obesity	3.26e-06	3.74e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—RHOA—obesity	3.26e-06	3.74e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—obesity	3.24e-06	3.73e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOC3—obesity	3.24e-06	3.72e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOE—obesity	3.24e-06	3.72e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT2—obesity	3.23e-06	3.71e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CD—obesity	3.22e-06	3.71e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3R1—obesity	3.22e-06	3.7e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CAV1—obesity	3.21e-06	3.69e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOA1—obesity	3.2e-06	3.68e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FOXO3—obesity	3.19e-06	3.66e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—obesity	3.18e-06	3.66e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARA—obesity	3.18e-06	3.65e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRB2—obesity	3.18e-06	3.65e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—obesity	3.16e-06	3.63e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CETP—obesity	3.14e-06	3.61e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SOCS1—obesity	3.13e-06	3.59e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POMC—obesity	3.12e-06	3.58e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SDC1—obesity	3.11e-06	3.57e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CD—obesity	3.1e-06	3.56e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—INS—obesity	3.1e-06	3.56e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SOCS3—obesity	3.09e-06	3.55e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AGT—obesity	3.08e-06	3.54e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKR1C3—obesity	3.06e-06	3.51e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3R1—obesity	3.05e-06	3.5e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—obesity	3.05e-06	3.5e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNB3—obesity	3.03e-06	3.48e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOE—obesity	3.02e-06	3.47e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SCARB1—obesity	3.01e-06	3.46e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CAV1—obesity	2.99e-06	3.44e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOA1—obesity	2.98e-06	3.43e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TYK2—obesity	2.98e-06	3.43e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CB—obesity	2.98e-06	3.42e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF2—obesity	2.97e-06	3.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—RHOA—obesity	2.96e-06	3.4e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNAS—obesity	2.95e-06	3.38e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3R1—obesity	2.93e-06	3.36e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SREBF1—obesity	2.92e-06	3.36e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CG—obesity	2.92e-06	3.36e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOB—obesity	2.88e-06	3.31e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CD—obesity	2.88e-06	3.31e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GOT2—obesity	2.84e-06	3.27e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—obesity	2.84e-06	3.26e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—obesity	2.82e-06	3.24e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL5—obesity	2.82e-06	3.24e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CB—obesity	2.81e-06	3.23e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—obesity	2.79e-06	3.2e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—FASN—obesity	2.78e-06	3.2e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POMC—obesity	2.78e-06	3.2e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—BCHE—obesity	2.77e-06	3.18e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—INS—obesity	2.77e-06	3.18e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LPL—obesity	2.75e-06	3.16e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FOXO1—obesity	2.73e-06	3.14e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RPS6KB1—obesity	2.73e-06	3.14e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CG—obesity	2.72e-06	3.13e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3R1—obesity	2.72e-06	3.12e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—obesity	2.72e-06	3.12e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CB—obesity	2.7e-06	3.11e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP2E1—obesity	2.67e-06	3.07e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NQO1—obesity	2.64e-06	3.04e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—obesity	2.63e-06	3.02e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POMC—obesity	2.59e-06	2.98e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—INS—obesity	2.58e-06	2.96e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CD—obesity	2.57e-06	2.95e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCD—obesity	2.54e-06	2.92e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—obesity	2.54e-06	2.91e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC2A4—obesity	2.53e-06	2.91e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GCG—obesity	2.53e-06	2.91e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CB—obesity	2.51e-06	2.88e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYCS—obesity	2.5e-06	2.87e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—obesity	2.48e-06	2.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2A—obesity	2.48e-06	2.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—C3—obesity	2.48e-06	2.85e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GGT1—obesity	2.45e-06	2.82e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GOT1—obesity	2.45e-06	2.82e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3R1—obesity	2.43e-06	2.79e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—obesity	2.43e-06	2.79e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NCOA1—obesity	2.42e-06	2.78e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CD—obesity	2.39e-06	2.75e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP19A1—obesity	2.38e-06	2.74e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—STK11—obesity	2.38e-06	2.74e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—obesity	2.36e-06	2.72e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IRS2—obesity	2.36e-06	2.71e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGT—obesity	2.36e-06	2.71e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOE—obesity	2.31e-06	2.65e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LEP—obesity	2.31e-06	2.65e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CAV1—obesity	2.29e-06	2.63e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOA1—obesity	2.28e-06	2.62e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3R1—obesity	2.26e-06	2.6e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—obesity	2.26e-06	2.6e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CB—obesity	2.24e-06	2.57e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—obesity	2.22e-06	2.55e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—COMT—obesity	2.22e-06	2.55e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ESR1—obesity	2.2e-06	2.53e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GNB3—obesity	2.18e-06	2.51e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARGC1A—obesity	2.18e-06	2.51e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCB—obesity	2.18e-06	2.5e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—F2—obesity	2.18e-06	2.5e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CA—obesity	2.18e-06	2.5e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMOX1—obesity	2.17e-06	2.5e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BAD—obesity	2.15e-06	2.47e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GNAS—obesity	2.13e-06	2.44e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CB—obesity	2.09e-06	2.4e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CG—obesity	2.08e-06	2.39e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOB—obesity	2.08e-06	2.39e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—obesity	2.07e-06	2.38e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IRS1—obesity	2.06e-06	2.37e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPL—obesity	1.99e-06	2.29e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—POMC—obesity	1.98e-06	2.28e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INS—obesity	1.97e-06	2.27e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL2—obesity	1.94e-06	2.23e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPX1—obesity	1.94e-06	2.23e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1—obesity	1.91e-06	2.19e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT2—obesity	1.91e-06	2.19e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CD36—obesity	1.89e-06	2.17e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CD—obesity	1.83e-06	2.1e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CA—obesity	1.81e-06	2.08e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SERPINE1—obesity	1.81e-06	2.08e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—obesity	1.79e-06	2.06e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—obesity	1.78e-06	2.04e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TYK2—obesity	1.76e-06	2.02e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARA—obesity	1.76e-06	2.02e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RHOA—obesity	1.75e-06	2.01e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—obesity	1.73e-06	1.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3R1—obesity	1.73e-06	1.99e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CA—obesity	1.71e-06	1.97e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AGT—obesity	1.7e-06	1.95e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOE—obesity	1.67e-06	1.92e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CAV1—obesity	1.65e-06	1.9e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA1—obesity	1.65e-06	1.89e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CA—obesity	1.65e-06	1.89e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MTOR—obesity	1.6e-06	1.83e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CB—obesity	1.6e-06	1.83e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CA—obesity	1.53e-06	1.76e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CG—obesity	1.5e-06	1.73e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—obesity	1.48e-06	1.7e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—obesity	1.46e-06	1.68e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—obesity	1.45e-06	1.67e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POMC—obesity	1.43e-06	1.65e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—INS—obesity	1.42e-06	1.64e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—obesity	1.4e-06	1.61e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—obesity	1.39e-06	1.59e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CA—obesity	1.37e-06	1.57e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK8—obesity	1.35e-06	1.55e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—obesity	1.35e-06	1.55e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CD—obesity	1.32e-06	1.52e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—obesity	1.31e-06	1.5e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CA—obesity	1.27e-06	1.46e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3R1—obesity	1.25e-06	1.44e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—obesity	1.25e-06	1.44e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—obesity	1.25e-06	1.43e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT3—obesity	1.23e-06	1.42e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CB—obesity	1.15e-06	1.32e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MYC—obesity	1.15e-06	1.32e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—obesity	1.14e-06	1.31e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—obesity	1.14e-06	1.31e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—obesity	1.12e-06	1.28e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—obesity	1.04e-06	1.19e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CA—obesity	9.73e-07	1.12e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—obesity	8.62e-07	9.9e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—obesity	7.95e-07	9.14e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CA—obesity	7.03e-07	8.07e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—obesity	5.74e-07	6.6e-06	CbGpPWpGaD
